Overview
- 5 inspections across 5 sites are on record.
- 1 Form 483 observation is attributed to this investigator.
- Most recent recorded activity is 2025-11-07.
At a glance
Inspections
5
Sites
5
Observations
1
Career since
Jan 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Allergan Sales, LLC | 7 Nov 2025 | Human Drugs | On file |
| Daewoong Pharmaceutical Co. Ltd. | 15 Oct 2024 | Human Drugs | On file |
| Revance Therapeutics, Inc. | 2 Jul 2021 | Human Drugs | On file |
| Revance Therapeutics, Inc. | 1 Jul 2021 | Human Drugs | |
| Alexion Pharmceuticals, Inc. | 21 Jan 2015 | Animal Drugs & Feeds |
Sites inspected
Allergan Sales, LLCIrvine, United States1 insp.
Daewoong Pharmaceutical Co. Ltd.Hwaseong, Korea (the Republic of)1 insp.
Revance Therapeutics, Inc.Newark, United States1 insp.
Revance Therapeutics, Inc.Moffett Field, United States1 insp.
Alexion Pharmceuticals, Inc.Holden, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Carla J Lundi2 shared
Md Kamal Hossain1 shared
Priscilla A Amador Do Amaral1 shared
Madushini N Dharmasena1 shared
Della Shin1 shared
Zhong Li1 shared
Malini Wileman1 shared
Brinda Dass1 shared
Harlan J Howard1 shared
Darin S Wiegers1 shared
Full investigator report
Get the verbatim findings behind Joao A Pedras Vasconcel's 1 observation
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site